National Association of Testing Authorities, Australia
Scope of Accreditation
360biolabs Pty Ltd
Site
St Kilda Road Facility
Accreditation No.
15805
Site No.
25695
Date of Accreditation
08 Apr 2024
Contact
Ms Angela Luttick P: +61 (03) 92822184
Availability
Services conditionally available to external clients
Scope of Accreditation
St Kilda Road Facility
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
| Service | Product | Determinant | Technique | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis in support of clinical trials and/or pre-clinical studies | Animal biological samples; Human biological samples | Impact of pharmaceuticals and biological agents on the diagnosis and treatment outcomes for human disease and disorders; Pharmacodynamics (PD) parameters; Pharmacokinetic (PK) parameters | ELISpot assays; Flow cytometry; Measurement of infectious titre - TCID50 and plaque assays; Multiplex assays; PCR - Quantitative (qPCR) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capability Projects are managed in accordance with the GCLP Principles interpreted for research. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Impact of pharmaceuticals and biological agents on the diagnosis and treatment outcomes for human disease and disorders; Pharmacodynamics (PD) parameters; Pharmacokinetic (PK) parameters | Enzyme linked immunosorbent assay (ELISA); Haemagglutination inhibition assays; Isolation and storage of peripheral blood and bone marrow mononuclear cells; LC-MS-MS; Viral culture immunogenicity testing - Anti-drug antibodies (ADA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capability Projects are managed in accordance with the GCLP Principles interpreted for research. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
15805
Site No.
25695
Print date
23 Nov 2024
END OF SCOPE